Previous 10 | Next 10 |
home / stock / seovf / seovf news
Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 Million Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / LONDON, ON , Feb. 4, 2021 /CNW/ - Sernova Corp. ("Sernova" or th...
(TheNewswire) LONDON, ONTARIO – TheNewswire - February 4, 2021 – Sernova Corp. (TSXV:SVA) (OTCQB:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce the start of trading of Sernova ...
Sernova (SEOVF) to sell 8.35M units at a price of C$1.20 per unit for gross proceeds of ~C$10M via underwriters.Net proceeds will be used to advance the company's clinical development program, including its US Phase I/II Cell Pouch clinical trial, expand R&D programs, including...
Sernova Corp. Announces C$10 Million Bought Deal Offering of Units Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / LONDON, ON , Feb. 3, 2021 /CNW/ - Sernova Corp. ("Sernova" or the "Company") ...
(TheNewswire) LONDON, ONTARIO – TheNewswire - February 3, 202 1 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr. Sam Wiseman, BSc, MD, ...
(TheNewswire) London, ON – TheNewswire – February 2 2021 - On the heels of recent partnership interest and conference presentations , Global News London’s Jess Brady took time took time to truly explore ...
(TheNewswire) Sernova’s Cell Pouch platform and cell therapy expertise being used in multiple collaborations with global pharmaceutical companies LONDON, ONTARIO – TheNewswire - January 28, 2021 – Sernova Corp. (TSXV...
(TheNewswire) LONDON, ONTARIO – TheNewswire - January 25, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company is pleased to announce that in recent weeks it has received gros...
(TheNewswire) LONDON, ONTARIO – TheNewswire - January 21, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company announced today that Dr. Philip Toleikis, President and CEO has been invited to parti...
Sernova ([[SEOVF]] +61.9%) announces that its principal clinical investigator, presented additional positive preliminary safety and efficacy data for its diabetes Cell Pouch at the 2021 American Society of Transplant Surgeons Winter Symposium.Sernova’s Cell Pouch transplante...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...